Intellectus Partners’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.88M | Hold |
548,133
| – | – | 0.41% | 66 |
|
|
2025
Q1 | $1.22M | Buy |
548,133
+600
| +0.1% | +$1.34K | 0.3% | 96 |
|
|
2024
Q4 | $1.6M | Buy |
547,533
+2,000
| +0.4% | +$5.86K | 0.36% | 77 |
|
|
2024
Q3 | $1.42M | Hold |
545,533
| – | – | 0.36% | 84 |
|
|
2024
Q2 | $1.61M | Buy |
545,533
+3,750
| +0.7% | +$11.1K | 0.44% | 62 |
|
|
2024
Q1 | $2.45M | Sell |
541,783
-345,500
| -39% | -$1.57M | 0.65% | 40 |
|
|
2023
Q4 | $5.07M | Buy |
887,283
+10,650
| +1% | +$60.8K | 1.46% | 10 |
|
|
2023
Q3 | $4.03M | Sell |
876,633
-800
| -0.1% | -$3.68K | 1.28% | 10 |
|
|
2023
Q2 | $5.67M | Buy |
877,433
+4,950
| +0.6% | +$32K | 1.7% | 8 |
|
|
2023
Q1 | $6.58M | Buy |
872,483
+3,900
| +0.4% | +$29.4K | 2.08% | 6 |
|
|
2022
Q4 | $8.8M | Sell |
868,583
-222,922
| -20% | -$2.26M | 3.06% | 1 |
|
|
2022
Q3 | $10.8M | Buy |
1,091,505
+1,750
| +0.2% | +$17.3K | 3.84% | 3 |
|
|
2022
Q2 | $11.6M | Sell |
1,089,755
-22,224
| -2% | -$237K | 3.99% | 2 |
|
|
2022
Q1 | $10.8M | Sell |
1,111,979
-80,400
| -7% | -$784K | 3.24% | 3 |
|
|
2021
Q4 | $17.1M | Sell |
1,192,379
-31,050
| -3% | -$444K | 4.35% | 2 |
|
|
2021
Q3 | $24.5M | Buy |
1,223,429
+16,450
| +1% | +$330K | 5.93% | 1 |
|
|
2021
Q2 | $26.6M | Buy |
+1,206,979
| New | +$26.6M | 5.99% | 1 |
|